Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Rilpivirine”

125 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 125 results

Early research (Phase 1)Study completedNCT00739622
What this trial is testing

TMC278-TiDP6-C136: Effect of TMC278 on Ethinylestradiol and Norethindrone in Healthy Women.

Who this might be right for
HIVAIDSOral Contraceptive
Tibotec Pharmaceuticals, Ireland 18
Early research (Phase 1)Study completedNCT03984838
What this trial is testing

Study to Evaluate Pharmacokinetics, Safety and Tolerability of Dolutegravir and Rilpivirine (JULUCA™) 50 Milligram (mg)/25 mg Tablets in Healthy Subjects of Japanese Descent

Who this might be right for
HIV Infections
ViiV Healthcare 16
Large-scale testing (Phase 3)Active Not RecruitingNCT05917509
What this trial is testing

Evaluate the Efficacy, Safety, Participant Choice and Preference of an Oral Once-daily Regimen or a Long-acting Injectable Regimen Every Two Months for Treatment of Human Immunodeficiency Virus (HIV-1) in Adults Who Have Not Previously Taken Antiretroviral Therapy

Who this might be right for
HIV Infections
ViiV Healthcare 171
Not applicableNot Yet RecruitingNCT06635421
What this trial is testing

The Expand Study-Pharmacist Administered Long Acting Cabotegravir + Rilpivirine to Expand Access for People With HIV

Who this might be right for
HIV I Infection
MetroHealth Medical Center 164
Early research (Phase 1)Study completedNCT02561936
What this trial is testing

Relative Bioavailability of Three Oral Formulations Candidates of Rilpivirine for Potential Pediatric Use Compared to Oral Tablet

Who this might be right for
Healthy
Janssen Sciences Ireland UC 32
Early research (Phase 1)Study completedNCT01288755
What this trial is testing

TMC278-TiDP6-C153 - A Study in Healthy Volunteers Investigating the Pharmacokinetic Interaction Between TMC278 and Raltegravir

Who this might be right for
HIV Infections
Tibotec Pharmaceuticals, Ireland 24
Large-scale testing (Phase 3)Study completedNCT00540449
What this trial is testing

TMC278-TiDP6-C209: A Clinical Trial in Treatment Naive HIV-1 Patients Comparing TMC278 to Efavirenz in Combination With Tenofovir + Emtricitabine.

Who this might be right for
HIV InfectionsHIV-1Human Immunodeficiency Virus Type 1
Tibotec Pharmaceuticals, Ireland 694
Not applicableActive Not RecruitingNCT06518408
What this trial is testing

A Real-life Study of the Use of Cabotegravir Plus Rilpivirine Long-acting in ART-experienced Pre-treated People With HIV

Who this might be right for
Human Immunodeficiency Virus
University Hospital Virgen de las Nieves 287
Not applicableEnded earlyNCT05096949
What this trial is testing

Implementing Cabenuva in Arkansas HIV Programs

Who this might be right for
HIV-1-infectionMedication AdherenceSatisfaction, Patient
University of Arkansas 1
Not applicableLooking for participantsNCT06424964
What this trial is testing

Use of Long-Acting Injectable Cabotegravir/Rilpivirine for the Treatment of HIV in Belgium

Who this might be right for
Human Immunodeficiency Virus
Belgian Research on AIDS and HIV Consortium 600
Not applicableStudy completedNCT04973254
What this trial is testing

Improving Treatment and Retention Adherence in Nontraditional Settings

Who this might be right for
HIV Infections
Boston Medical Center 25
Early research (Phase 1)Study completedNCT00744809
What this trial is testing

TMC278-TiDP6-C152: A Study to Assess the Effects of TMC278 and Efavirenz (EFV) on the QT/QTc Interval (Heart Conduction and Heart Rhythm) in Healthy Volunteers.

Who this might be right for
Human Volunteers
Tibotec Pharmaceuticals, Ireland 120
Large-scale testing (Phase 3)Study completedNCT02104700
What this trial is testing

Switch From Nevirapine-based Regimen to Once a Day Rilpivirine/Emtricitabine/Tenofovir

Who this might be right for
HIV
Philip Grant 150
Large-scale testing (Phase 3)Study completedNCT05601128
What this trial is testing

A Study Evaluating the Pharmacokinetics, Efficacy, Safety and Tolerability of CABENUVA

Who this might be right for
HIV-1-infectionHIV InfectionsHIV I Infection
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) 12
Not applicableStudy completedNCT05152953
What this trial is testing

Preparing for Pharmacy-based Delivery of Long-acting Injectable Antiretroviral Therapy (LAI-ART)

Who this might be right for
Hiv
University of California, San Francisco 63
Early research (Phase 1)Study completedNCT01467531
What this trial is testing

Evaluate the Pharmacokinetics and Safety of GSK1265744 and Rilpivirine and Dolutegravir and Rilpivirine in Healthy Adult Subjects

Who this might be right for
Infections, Human Immunodeficiency Virus and Hepatitis
ViiV Healthcare 28
Not applicableLooking for participantsNCT05663580
What this trial is testing

Cohort Study of HIV-positive People, Treated With Long Acting Antiretroviral Therapy

Who this might be right for
HIV Infections
Castagna Antonella 1,500
Large-scale testing (Phase 3)Study completedNCT01309243
What this trial is testing

Study to Evaluate the Safety and Efficacy of a Single Tablet Regimen of Emtricitabine/Rilpivirine/Tenofovir Disoproxil Fumarate Compared With a Single Tablet Regimen of Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults

Who this might be right for
HIV-1 Infection
Gilead Sciences 799
Post-approval studies (Phase 4)Looking for participantsNCT06646562
What this trial is testing

Long Acting Cabotegravir Plus Rilpivirine in People Living with HIV-1 Aged ≥ 60 Years for 24 Months.

Who this might be right for
HIV-1 Infected Adults with Controlled Viremia
Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia 120
Large-scale testing (Phase 3)Study completedNCT05896761
What this trial is testing

A Sub-study of Cabotegravir (CAB) and Rilpivirine (RPV) in Human Immunodeficiency Viruses (HIV)-Infected Participants

Who this might be right for
Human Immunodeficiency Virus Type 1 (HIV-1)
ViiV Healthcare 118
Load More Results